Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Belenos Biosciences is a company.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Cullinan Therapeutics received $280.0M in a Post Ipo Equity round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include MBX Biosciences, Chemomab, Brenig Therapeutics, Magenta Medical, Belenos Biosciences. These companies were founded in 2020 or later.